Assertio Holdings | DEPO - Operating Expenses

Stock Price
12.38
Daily Change
0.17 1.35%
Monthly
21.20%
Yearly
-1.97%
Q1 Forecast
0.88

Assertio Holdings reported $105.8M in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
ANI Pharmaceuticals USD 505.82M 309.62M Sep/2025
Assertio Holdings USD 105.8M 12.5M Sep/2025
Aurora Cannabis CAD 146.03M 27.79M Sep/2025
Cara Therapeutics USD 4.96M 2.38M Mar/2025
Daiichi Sankyo JPY 468.57B 15.34B Dec/2025
Ironwood Pharmaceuticals USD 57.33M 8.63M Dec/2024
J&J USD 18.97B 2.38B Dec/2025
Knight Therapeutics CAD 89.06M 2.02M Sep/2024
Merck USD 10.16B 558M Dec/2025
Nektar Therapeutics USD 85.09M 109.3M Sep/2025
Omeros USD 59.16M 20.13M Jun/2024
Pfizer USD 12.91B 79.89B Dec/2025
Teva Pharmaceutical Industries USD 4.22B 812M Dec/2025